These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma. Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410 [TBL] [Abstract][Full Text] [Related]
9. Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths. Salpeter SR; Buckley NS; Ormiston TM; Salpeter EE Ann Intern Med; 2006 Jun; 144(12):904-12. PubMed ID: 16754916 [TBL] [Abstract][Full Text] [Related]
11. Formoterol. An update of its pharmacological properties and therapeutic efficacy in the management of asthma. Bartow RA; Brogden RN Drugs; 1998 Feb; 55(2):303-22. PubMed ID: 9506248 [TBL] [Abstract][Full Text] [Related]
12. Long-acting beta(2)-agonists in management of childhood asthma: A critical review of the literature. Bisgaard H Pediatr Pulmonol; 2000 Mar; 29(3):221-34. PubMed ID: 10686044 [TBL] [Abstract][Full Text] [Related]
13. Long acting beta-agonists versus theophylline for maintenance treatment of asthma. Shah L; Wilson AJ; Gibson PG; Coughlan J Cochrane Database Syst Rev; 2003; (3):CD001281. PubMed ID: 12917905 [TBL] [Abstract][Full Text] [Related]
16. Recent trends in the use of inhaled beta 2-adrenergic agonists and inhaled corticosteroids in Saskatchewan. Habbick B; Baker MJ; McNutt M; Cockcroft DW CMAJ; 1995 Nov; 153(10):1437-43. PubMed ID: 7585370 [TBL] [Abstract][Full Text] [Related]
17. Safety of regular use of long-acting beta agonists as monotherapy or added to inhaled corticosteroids in asthma. A systematic review. Rodrigo GJ; Moral VP; Marcos LG; Castro-Rodriguez JA Pulm Pharmacol Ther; 2009 Feb; 22(1):9-19. PubMed ID: 19026757 [TBL] [Abstract][Full Text] [Related]
18. Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events. Cates CJ; Lasserson TJ Cochrane Database Syst Rev; 2009 Oct; (4):CD007695. PubMed ID: 19821436 [TBL] [Abstract][Full Text] [Related]
19. Dose-response of inhaled drugs in asthma. An update. Clark DJ; Lipworth BJ Clin Pharmacokinet; 1997 Jan; 32(1):58-74. PubMed ID: 9012556 [TBL] [Abstract][Full Text] [Related]
20. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma. Ducharme FM; Lasserson TJ; Cates CJ Cochrane Database Syst Rev; 2006 Oct; (4):CD003137. PubMed ID: 17054161 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]